Single Point Partners’s Eli Lilly LLY Stock Holding History

Single Point Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Buy	+201	New	+$205K	0.04%	90
2026 Q1	–	Sell	-206	Closed	-$221K	–	87
2025 Q4	$221K	Buy	+206	New	+$197K	0.04%	80
2025 Q3	–	Sell	-302	Closed	-$235K	–	90
2025 Q2	$235K	Hold	302	–	–	0.05%	78
2025 Q1	$249K	Sell	302 -24	-7%	-$20K	0.06%	73
2024 Q4	$252K	Buy	+326	New	+$270K	0.06%	65
2023 Q2	–	Sell	-1,331	Closed	-$457K	–	115
2023 Q1	$457K	Buy	1,331 +51	+4%	+$17.2K	0.1%	76
2022 Q4	$468K	Buy	1,280 +20	+2%	+$7.09K	0.11%	75
2022 Q3	$408K	Buy	1,260 +35	+3%	+$11.1K	0.11%	73
2022 Q2	$397K	Buy	1,225 +160	+15%	+$48K	0.11%	73
2022 Q1	$305K	Buy	1,065 +309	+41%	+$79.5K	0.08%	78
2021 Q4	$209K	Buy	+756	New	+$192K	0.06%	79
2021 Q3	–	Sell	-1,046	Closed	-$240K	–	62
2021 Q2	$240K	Sell	1,046 -286	-21%	-$57.4K	0.08%	62
2021 Q1	$247K	Buy	+1,332	New	+$261K	0.09%	65

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Single Point Partners's LLY Position: Q2 2026 in Review

Single Point Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 201 shares worth $241K. The stake represents 0.04% of the portfolio and ranks #90 among its holdings. This is a return to the name: Single Point Partners previously reported a position in LLY as recently as Q4 2025.

Single Point Partners first reported a position in LLY in Q1 2021 and has held it in 13 quarters since. The position peaked at $468K in Q4 2022. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Single Point Partners held 201 shares of Eli Lilly worth $241K as of Q2 2026.
Eli Lilly was a new Single Point Partners position in Q2 2026.
Eli Lilly made up 0.04% of Single Point Partners's portfolio in Q2 2026, its #90 holding.
Single Point Partners first reported a position in Eli Lilly in Q1 2021 and has held it in 13 quarters since.
Single Point Partners's Eli Lilly position peaked at $468K in Q4 2022.
4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Single Point Partners's 13F filing for Q2 2026, filed 16 Jul 2026.